Description
Product Description
The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.
Product Specifications
| Product Specifications | |
| Application | FC |
| Reactivity | Human |
| Conjugation | APC |
| Peptide Sequence | YMDGTMSQV |
| Class | Class I |
| Sequence Location | 368-376 |
| MHC Allele | A*02:01 |
Documents & Links
| Documents & Links for HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC | |
| Datasheet | HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC Datasheet |
| Documents & Links for HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC | |
| Datasheet | HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC Datasheet |
Citations
| Citations for HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC – 1 Found |
| Akiyama, Yasuto; Tanosaki, Ryuji; Inoue, Naoki; Shimada, Makiko; Hotate, Yukie; Yamamoto, Akifumi; Yamazaki, Naoya; Kawashima, Ichiro; Nukaya, Ikuei; Takesako, Kazutoh; Maruyama, Kouji; Takaue, Yoichi; Yamaguchi, Ken. Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells. Journal Of Translational Medicine. 2005;3(1):4. PubMed |
